Quality Systems, Inc. Changes Name to NextGen Healthcare, Inc.
September 07 2018 - 7:30AM
Business Wire
Company to Trade on Nasdaq as NXGN
Quality Systems, Inc. (NASDAQ:QSII) announced today that the
company has changed its corporate name to NextGen Healthcare, Inc.
(Effective September 10, 2018, NASDAQ:NXGN). On September 10, 2018,
the company’s securities listed on The NASDAQ Global Select Market
will cease trading under the symbol “QSII” and will begin trading
under the new symbol “NXGN.”
The name change was effectuated by a merger pursuant to Section
1110(d) of the California Corporations Code. The name change was
effective as of September 6, 2018.
The name change does not affect the rights of the company’s
security holders and the company’s current leadership structure
will remain in place. The company’s transfer agent will contact the
company’s shareholders regarding the tender and exchange of share
certificates reflecting the old company name. The company’s new
Committee on Uniform Securities Identification Procedures (“CUSIP”)
Number is 65343C 102.
“Our clients have known us as NextGen Healthcare for nearly 20
years, and now is the time to align our investor-facing and
commercial-facing identities,” said Rusty Frantz, NextGen
Healthcare’s President and CEO. “Today’s announcement is a
significant milestone in our journey of aligning and simplifying
our organization to deliver a better future for our clients,
employees and investors.”
About NextGen Healthcare, Inc.
NextGen Healthcare, Inc. provides a range of software, services,
and analytics solutions to medical and dental group practices. The
company's portfolio delivers foundational capabilities to empower
physician success, enrich the patient care experience, and enable
the transition to value-based healthcare. Visit www.nextgen.com for
additional information.
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within
the meaning of the federal securities laws, including but not
limited to, statements regarding future events, developments in the
healthcare sector and regulatory framework, the company's future
performance, as well as management's expectations, beliefs,
intentions, plans, estimates or projections relating to the future
(including, without limitation, statements concerning revenue, net
income, and earnings per share). Risks and uncertainties exist that
may cause the results to differ materially from those set forth in
these forward-looking statements. Factors that could cause the
anticipated results to differ from those described in the
forward-looking statements and additional risks and uncertainties
are set forth in Part I, Item A of our most recent Annual Report on
Form 10-K and subsequently filed Quarterly Reports on Form 10-Q,
including but not limited to: the volume and timing of systems
sales and installations; length of sales cycles and the
installation process; the possibility that products will not
achieve or sustain market acceptance; seasonal patterns of sales
and customer buying behavior; impact of incentive payments under
The American Recovery and Reinvestment Act on sales and the ability
of the company to meet continued certification requirements;
uncertainties related to the future impact of U.S. tax reform; the
impact of governmental and regulatory agency investigations; the
development by competitors of new or superior technologies; the
timing, cost and success or failure of new product and service
introductions, development and product upgrade releases; undetected
errors or bugs in software; product liability; changing economic,
political or regulatory influences in the health-care industry;
changes in product-pricing policies; availability of third-party
products and components; competitive pressures including product
offerings, pricing and promotional activities; the company's
ability or inability to attract and retain qualified personnel;
possible regulation of the company's software by the U.S. Food and
Drug Administration; changes of accounting estimates and
assumptions used to prepare the prior periods' financial
statements; disruptions caused by acquisitions of companies,
products, or technologies; and general economic conditions. A
significant portion of the company's quarterly sales of software
product licenses and computer hardware is concluded in the last
month of a fiscal quarter, generally with a concentration of such
revenues earned in the final ten business days of that month. Due
to these and other factors, the company's revenues and operating
results are very difficult to forecast. A major portion of the
company's costs and expenses, such as personnel and facilities, are
of a fixed nature and, accordingly, a shortfall or decline in
quarterly and/or annual revenues typically results in lower
profitability or losses. As a result, comparison of the company's
period-to-period financial performance is not necessarily
meaningful and should not be relied upon as an indicator of future
performance. These forward-looking statements speak only as of the
date hereof. The company undertakes no obligation to publicly
update any forward-looking statements, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180907005036/en/
Media:NextGen Healthcare, Inc.Jennifer Cohen,
949-255-2600 ext.
74334jecohen@nextgen.comorInvestors:Westwicke PartnersBob
East or Asher Dewhurst443-213-0500
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Sep 2024 to Oct 2024
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Oct 2023 to Oct 2024